Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathis Grossmann

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 3, 2019
Selective Loss of Levator Ani and Leg Muscle Volumes in Men Undergoing Androgen Deprivation TherapyAda S Cheung, Christopher Cunningham, Dong-Kyoon Daniel Ko, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2023
Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up StudyDavid J Handelsman, Mathis Grossmann, Bu B Yeap, et al.
Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2025
Response to Letter to the Editor From Lin et al: "Testosterone Treatment, Weight Loss, and Health-Related Quality of Life and Psychosocial Function in Men: A 2-Year Randomized Controlled Trial"Mathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 5, 2020
Osteoporosis in Parkinson's Disease: Relevance of Distal Radius Dual-Energy X-Ray Absorptiometry (DXA) and SarcopeniaYan Jing Tan, Shen-Yang Lim, Voon Wei Yong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCTMark Ng Tang Fui, Rudolf Hoermann, Karen Bracken, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2024
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled TrialMathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Parkinsonism & Related Disorders|July 3, 2020
Progressive and accelerated weight and body fat loss in Parkinson's disease: A three-year prospective longitudinal studyVoon Wei Yong, Yan Jing Tan, Yi-De Ng, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|January 3, 2019
Selective Loss of Levator Ani and Leg Muscle Volumes in Men Undergoing Androgen Deprivation TherapyAda S Cheung, Christopher Cunningham, Dong-Kyoon Daniel Ko, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2023
Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up StudyDavid J Handelsman, Mathis Grossmann, Bu B Yeap, et al.
Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2025
Response to Letter to the Editor From Lin et al: "Testosterone Treatment, Weight Loss, and Health-Related Quality of Life and Psychosocial Function in Men: A 2-Year Randomized Controlled Trial"Mathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 5, 2020
Osteoporosis in Parkinson's Disease: Relevance of Distal Radius Dual-Energy X-Ray Absorptiometry (DXA) and SarcopeniaYan Jing Tan, Shen-Yang Lim, Voon Wei Yong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCTMark Ng Tang Fui, Rudolf Hoermann, Karen Bracken, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2024
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled TrialMathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Parkinsonism & Related Disorders|July 3, 2020
Progressive and accelerated weight and body fat loss in Parkinson's disease: A three-year prospective longitudinal studyVoon Wei Yong, Yan Jing Tan, Yi-De Ng, et al.
Pageof 19